The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. The perception that CBD is a wonder-drug version of cannabis — particularly known for its uses to treat epilepsy — that doesn’t get you high.

CBD 122

CBD Research and Development Epilepsy Extraction 122

MMJ Recs

DECEMBER 17, 2023

Here’s some insight into what the program involves: Intractable Epilepsy Focus: The TCUP is highly focused, primarily catering to individuals diagnosed with one of a specific number of qualifying conditions (more on this below). Current Texas Medical Marijuana Regulations CBD laws in Texas are governed by the Compassionate Use Program.

Law 52

Law Clinical Trials Dispensary Programs 52

Cannabis Law Report

JULY 13, 2019

clinical trials have been made by Members of Parliament. After months of interviews and weighing-up reams of evidence The House of Commons Health and Social Care Committee has issued its latest report; ‘ Drugs policy: medicinal cannabis’. CBD Testers.co

Research and Development 40

Research and Development Clinical Trials Epilepsy Patients 40

MMJ Recs

JULY 5, 2024

Neurological Disorders Research suggests THC may benefit neurological conditions such as epilepsy, multiple sclerosis (MS), and Parkinson’s disease. Numerous clinical trials are underway to further investigate THC’s efficacy, safety, and potential interactions with other medications as well.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. The STATES Act, for example, represents a step toward allowing states to determine their cannabis policies without federal interference.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JULY 15, 2019

ACM takes in consideration the characteristics of medical cannabis preparations and substances, and is a simplified version of the marketing authorization required for medicinal products to some extent (for instance, no clinical trials are required). Author: João Taborda da Gama. 351 914 725 808. joao.gama@gamagloria.com.

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

JULY 15, 2022

The schedule eight pharmaceutical medicine has gained federal approval to treat conditions including cancer-related pain, nausea and vomiting, multiple sclerosis and epilepsy, and for use in palliative care. We are at the crossroads of good agriculture meets good health care which meets great policy. ABC Rural: Jennifer Nichols ).

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera is an accomplished cross-functional leader in the healthcare industry, with over 20 years of experience in the development and implementation of complex market access strategies including health policy, pricing and reimbursement, contracts and coding.

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Conclusions. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Canna Law Blog

OCTOBER 5, 2022

We could see medical marijuana in Japan in the near future, which would be huge for Asian cannabis policy and the world. Last year, it recommended that the government allow the use of marijuana to treat “refractory epilepsy.” Japan also ratified the Single Convention on Narcotic Drugs.

Marijuana 98

Marijuana Seed-To-Sale Clinical Trials Epilepsy 98

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

The Cannigma

MAY 7, 2021

This is where the crux of the issue is, if you are a patient then you have epilepsy or your child has epilepsy, you want a qualified product that you can rely on that has the same level of provision in relation to the manufacturing process as any other medicine that you would take. MSO: Let’s pivot for a minute.

Supply Chain 122

Supply Chain Patients Access Hemp 122

Canna Law Blog

APRIL 17, 2020

THC binds to the CB1 receptors, but the way that CBD interacts with ECS is not fully understood in humans or animals, despite the fact that Epidiolex has been approved as a drug for treating epilepsy. Since then, many other states, including Utah and Texas have adopted similar labeling standards, making Indiana a leader in Hemp CBD policy.

Pets 74

Pets Hemp CBD Food 74

Cannabis Law Report

AUGUST 23, 2022

The Muda president claimed that many parents give medical cannabis to children for mental health issues, epilepsy, and ADHD, as he asked for “sympathy and compassion” for people who take marijuana for medical purposes, pending formal authorisation of such products in Malaysia. “I He is scheduled to visit Siam Cannabis Land, a cannabis farm.

Extraction 52

Extraction Clinical Trials Hemp Epilepsy 52

Cannabis Law Report

FEBRUARY 15, 2019

There is even published research, derived from clinical trials, on the potential uses of cannabinoids to manage seizures and epilepsy, cited the ministries. The ministries asserted that the policies are underpinned by research. These can be administered through pharmaceutical products such as oral solutions and sprays.

Medicine 45

Medicine Pharmaceutical Law Cannabinoids 45

Cannabis Law Report

DECEMBER 30, 2019

After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019. Erik Altieri.

Legislation 45

Legislation Patients Access Banking 45

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.

Legalization 130

Legalization Patients Education Dispensary 130

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. This is true even if the CBD comes from industrial hemp.

Law 40

Law Seed-To-Sale Hemp Recreational 40

Veriheal

NOVEMBER 7, 2024

This shift in federal drug policy would allow cannabis-derived drugs to be legally available by prescription, making the drug more accessible to patients and medical researchers. drug policy and public opinion regarding cannabis’ status as a medicine. Looking Ahead: The Future of U.S.

DEA 97

DEA Policy Chronic Pain Marijuana 97